KCTD16

KCTD16 is an auxiliary subunit of metabotropic GABAB receptors that shapes the kinetics, network consequences, and behavioral outputs of GABAB signaling in the nervous system (PMID:30971491, PMID:25196734). Its BTB/oligomerization domain assembles into an open pentamer whose interior accommodates a single GABAB2 C-terminal peptide; disruption of this interface abolishes both biochemical association and functional modulation of GABAB receptors and GIRK (Kir3) currents, defining the structural basis for its action (PMID:30971491). As an auxiliary subunit it increases GABA affinity at the receptor and differentially tunes G-protein activation (PMID:25196734), and it can hetero-oligomerize with KCTD12 through self-interacting T1 and H1 domains to generate receptor populations with kinetic properties distinct from either homo-oligomer, prolonging slow IPSCs in hippocampal neurons (PMID:28003345). Beyond gating G-protein output, KCTD16 serves as a molecular scaffold: it anchors HCN2/HCN3-containing channels to GABAB receptors in VTA dopamine neurons to limit the late phase of GABAB-mediated inhibition (PMID:39914775), and it is recruited together with Cav2.2 channels into presynaptic GABAB signaling complexes via direct binding to the vesicular protein synaptotagmin-11 (PMID:38698221). Distinct from other KCTD proteins, KCTD16 does not bind Cullin3 and therefore does not function as a canonical Cul3-dependent E3 ubiquitin ligase substrate adaptor (PMID:28963344). Through these activities KCTD16 regulates thalamic spindle oscillations (PMID:29106983), fear memory extinction and contextual fear (PMID:27717812), stress-related anxiety (PMID:39914775), and GABAB-dependent presynaptic inhibition of nociceptive transmission in the spinal dorsal horn (PMID:41592618).

1. 2014 Medium

   Established that KCTD16 is not merely a binding partner but an auxiliary subunit that functionally tunes GABAB receptor signaling, by showing it raises GABA affinity and shapes G-protein activation.

   Evidence [35S]GTPγS binding, inter-G-protein BRET, and Kir3 current recordings in CHO cells and hippocampal neurons

   PMID:25196734

   Open questions at the time

   • Quantitative magnitude of affinity change is small
   • Structural basis of the interaction was not resolved here
   • Did not address oligomeric state or hetero-oligomerization
2. 2016 High

   Resolved whether KCTD16 acts alone or combinatorially by demonstrating it hetero-oligomerizes with KCTD12 to confer unique Kir3 kinetics, explaining receptor subtype diversity in native tissue.

   Evidence Reciprocal Co-IP from mouse hippocampus, live-cell BRET, and electrophysiology in KCTD knockout neurons

   PMID:28003345

   Open questions at the time

   • Stoichiometry of mixed oligomers in vivo not defined
   • Functional consequences in non-hippocampal circuits not tested
3. 2016 Medium

   Connected KCTD16 to a behavioral phenotype, establishing it as a regulator of fear memory processing through its GABAB auxiliary role.

   Evidence Auditory and contextual fear conditioning/extinction in Kctd16 knockout and heterozygous mice

   PMID:27717812

   Open questions at the time

   • Circuit and synaptic locus mediating the behavior not pinpointed
   • Single behavioral paradigm
   • Molecular mechanism linking KO to extinction deficit not dissected
4. 2017 High

   Distinguished KCTD16 from canonical KCTD E3-ligase adaptors by showing its BTB domain forms an open pentamer yet, unlike KCTD10/13/17, fails to bind Cullin3.

   Evidence X-ray crystallography, SAXS, size-exclusion chromatography, and direct Cul3 binding assay

   PMID:28963344

   Open questions at the time

   • Why KCTD16 cannot engage Cul3 at the residue level not fully mapped
   • Did not test all family members
5. 2017 Medium

   Extended KCTD16 function to network-level activity by showing it shapes thalamic spindle oscillation strength and frequency through GABAB receptors.

   Evidence Electrical and optogenetic activation of thalamic spindles in slices from KCTD knockout mice with pharmacology

   PMID:29106983

   Open questions at the time

   • Cell-type-specific contribution within thalamic circuitry not resolved
   • Single primary method
6. 2019 High

   Provided the atomic-level mechanism for KCTD16's action by solving the open-pentamer structure bound to a single GABAB2 C-terminal peptide and validating the interface functionally.

   Evidence X-ray crystallography, interface mutagenesis, Co-IP, and GIRK current recordings

   PMID:30971491

   Open questions at the time

   • Structure of full-length KCTD16 with intact GABAB receptor not determined
   • Dynamics of pentamer–G-protein coupling not captured
7. 2019 Medium

   Demonstrated the KCTD16/GABAB interface is druggable and that ligand binding can remodel KCTD16 oligomerization, by developing a peptide inhibitor that drives hexamer formation.

   Evidence μSPOT peptide array, X-ray crystallography, SEC-MALS, and Co-IP from mouse brain lysates

   PMID:31509708

   Open questions at the time

   • In vivo efficacy of the inhibitor not shown
   • Functional consequence of hexamerization on signaling not established
8. 2024 High

   Revealed a scaffolding function beyond G-protein gating, showing KCTD16 anchors HCN2/HCN3 channels to GABAB receptors in VTA dopamine neurons to limit inhibitory duration and constrain stress-induced anxiety.

   Evidence Reciprocal Co-IP, optogenetics, patch-clamp, CRISPR conditional KO in VTA, pharmacology, and anxiety assays

   PMID:39914775

   Open questions at the time

   • Direct vs. indirect nature of KCTD16–HCN contact not structurally resolved
   • Generality across other HCN-expressing circuits untested
9. 2024 Medium

   Identified a trafficking/assembly route for presynaptic GABAB signaling, showing synaptotagmin-11 binds KCTD16 and Cav2.2 to recruit and stabilize GBR/Cav2.2 complexes at the membrane.

   Evidence Co-IP and Syt11 knockout mouse analysis of presynaptic GBR/Cav2.2 levels, neurotransmitter release, and presynaptic inhibition

   PMID:38698221

   Open questions at the time

   • KCTD16-specific requirement (vs. other auxiliary subunits) not isolated
   • Single lab
10. 2026 Medium

    Placed KCTD16 in sensory circuits by demonstrating it is required for GABAB-mediated presynaptic inhibition of nociceptive transmission and for full baclofen anti-allodynic efficacy.

    Evidence Immunohistochemistry, KCTD16 KO mice, von Frey/thermal/carrageenan behavioral assays, patch-clamp, and DRG calcium imaging

    PMID:41592618

    Open questions at the time

    • Whether the dorsal horn role uses the same hetero-oligomer/scaffold mechanisms as central circuits not established
    • Single lab
11. 2020 Medium

    Characterized cis-regulatory control of Kctd16 expression by identifying a dual enhancer-silencer intronic element that represses the gene in spermatocytes.

    Evidence Epigenetic profiling, reporter assays, and CRISPR deletion in GC-2spd(ts) cells with RT-PCR

    PMID:33121685

    Open questions at the time

    • Physiological function of KCTD16 in spermatocytes not defined
    • Trans-acting factors binding the element not identified

• How KCTD16's distinct functional modes — G-protein kinetic tuning, KCTD12 hetero-oligomerization, HCN anchoring, and Syt11-dependent presynaptic assembly — are combinatorially deployed across different neuron types and whether they share a common structural logic remains unresolved.
• No integrated model linking scaffolding and signaling roles in a single circuit
• Full-length receptor-complex structures lacking
• Non-neuronal/spermatocyte roles uncharacterized functionally